Hemmatazad, Hossein

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: Yes

Yes

Alongi, Filippo; Nicosia, Luca; Ricardi, Umberto; Scorsetti, Marta; Greto, Daniela; Balermpas, Panagiotis; Lievens, Yolande; Braam, Pètra; Alicja Jereczek-Fossa, Barbara; Stellamans, Karin; Ratosa, Ivica; Simek, Inga-Malin; Peulen, Heike; Dirix, Piet; Verbeke, Luc; Ramella, Sara; Hemmatazad, Hossein; Khanfir, Kaouthar; Geets, Xavier; Jeene, Paul; ... (2024). Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort. Radiotherapy and oncology, 199, p. 110466. Elsevier 10.1016/j.radonc.2024.110466

Guckenberger, Matthias; Billiet, Charlotte; Schnell, Daniel; Franzese, Ciro; Spałek, Mateusz; Rogers, Susanne; Stelmes, Jean-Jacques; Aebersold, Daniel M; Hemmatazad, Hossein; Zimmermann, Frank; Zimmer, Jörg; Zilli, Thomas; Bruni, Alessio; Baumert, Brigitta G; Nägler, Franziska; Gut, Philipp; Förster, Robert; Madani, Indira (2024). Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial. Cancer, 130(15), pp. 2713-2722. Wiley 10.1002/cncr.35310

Christ, Sebastian M; Alongi, Filippo; Ricardi, Umberto; Scorsetti, Marta; Livi, Lorenzo; Balermpas, Panagiotis; Lievens, Yolande; Braam, Pètra; Alicja Jereczek-Fossa, Barbara; Stellamans, Karin; Ratosa, Ivica; Widder, Joachim; Peulen, Heike; Dirix, Piet; Bral, Samuel; Ramella, Sara; Hemmatazad, Hossein; Khanfir, Kaouthar; Geets, Xavier; Jeene, Paul; ... (2024). Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 195(110235), p. 110235. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2024.110235

Hemmatazad, Hossein (May 2024). Stereotactic radiotherapy in metastatic breast cancer patients - a multicenter cohort study. Radiotherapy and oncology, 194(1), S559-S560. Elsevier

Aebersold, Daniel Matthias; Hemmatazad, Hossein (May 2024). SBRT vs. Conventional Radiotherapy for Painful Spinal Metastases: Randomised Phase 3 Trial. Radiotherapy and oncology, 194(1), S1902-S1905. Elsevier

Hemmatazad, Hossein (May 2024). Early Quality-of-Life after metastases-directed SBRT– results of the ESTRO & EORTC OligoCare cohort. Radiotherapy and oncology, 194(Supplement), S1952-S1954. Elsevier

Bachmann, Nicolas; Schmidhalter, Daniel; Corminboeuf, Frédéric; Manser, Peter; Ermis, Ekin; Aebersold, Daniel Matthias; Hemmatazad, Hossein (May 2024). CBCT-based online adaptive radiotherapy of esophageal cancer: first clinical experiences. Radiotherapy and oncology, 194(S1), S2214-S2215. Elsevier

Bultijnck, Renée; Van Hemelrijck, Mieke; Fonteyne, Valérie; Livi, Lorenzo; Jereczek-Fossa, Barbara Alicja; Hemmatazad, Hossein; Mayinger, Michael; Peulen, Heike; Verbeke, Luc; Ramella, Sara; Castro, Pablo; Tsoutsou, Pelagia; Stellamans, Karin; Shaukat, Adnan; Orazem, Miha; Jeene, Paul; Braam, Pètra; Verkooijen, Helena; Simek, Inga-Malin; Alongi, Filippo; ... (2024). Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort. Clinical and translational radiation oncology, 45 Elsevier 10.1016/j.ctro.2023.100715

Greto, D.; Van Hemelrijck, M.; Oppong, F.; Lievens, Y.; Ratosa, I.; Jereczek-Fossa, B.; Stellamans, K.; Peulen, H.; Verbeke, L.; Hemmatazad, H.; Ramella, S.; Braam, P.; Ivaldi, G.B.; Castro, P.; Shaukat, A.; Tsoutsou, P.; Olalla, S.C.; Sancho-Pardo, G.; Ost, P. and Guckenberger, M. (October 2023). 2140P Short-term quality-of-life after metastases-directed SBRT: Results of the prospective ESTRO & EORTC OligoCare cohort. Annals of oncology, 34, S1115. Elsevier 10.1016/j.annonc.2023.09.922

Bachmann, Nicolas; Schmidhalter, Daniel; Corminboeuf, Frédéric; Aebersold, D. M.; Manser, Peter; Hemmatazad, Hossein (18 September 2023). CBCT-based online adaptive radiotherapy of esophageal cancer: dosimetric benefits and first clinical experience. Strahlentherapie und Onkologie, 11(199), p. 1046. Springer

Hemmatazad, Hossein (18 September 2023). Watchful waiting after definitive radiochemotherapy in patients with esophageal cancer: independent predictors for recurrence. Strahlentherapie und Onkologie, 11(199), p. 1050. Springer

Riggenbach, Elena; Lössl, Kristina; Hemmatazad, Hossein (2023). [Dose escalation with brachytherapy to increase the organ preservation rate in rectal cancer]. Strahlentherapie und Onkologie, 199(7), pp. 694-696. Springer 10.1007/s00066-023-02101-w

Hemmatazad, Hossein (May 2023). OC-0269 Early toxicity of SBRT for oligometastatic cancer patients in the EORTC/ESTRO OligoCare cohort. Radiotherapy and oncology, 182(S1), S205-S205. Elsevier

Ermiş, Ekin; Althaus, Alexander; Blatti, Marcela; Uysal, Emre; Leiser, Dominic; Norouzi, Shokoufe; Riggenbach, Elena; Hemmatazad, Hossein; Ahmadli, Uzeyir; Wagner, Franca (2023). Therapy Resistance of Glioblastoma in Relation to the Subventricular Zone: What Is the Role of Radiotherapy? Cancers, 15(6) MDPI AG 10.3390/cancers15061677

Kroeze, Stephanie G C; Pavic, Matea; Stellamans, Karin; Lievens, Yolande; Becherini, Carlotta; Scorsetti, Marta; Alongi, Filippo; Ricardi, Umberto; Jereczek-Fossa, Barbara Alicja; Westhoff, Paulien; But-Hadzic, Jasna; Widder, Joachim; Geets, Xavier; Bral, Samuel; Lambrecht, Maarten; Billiet, Charlotte; Sirak, Igor; Ramella, Sara; Giovanni Battista, Ivaldi; Benavente, Sergi; ... (2023). Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium. The lancet oncology, 24(3), e121-e132. Elsevier 10.1016/S1470-2045(22)00752-5

Krcek, Reinhardt; Poel, Robert; Hemmatazad, Hossein; Reyes, Mauricio; Ermis, Ekin (17 January 2023). Variations in contouring brain target volumes and Organs at Risk on 3 T vs. 7 T MRI: An intra-rater/inter-rater analysis study. Strahlentherapie und Onkologie, p. 215. Springer

Kroeze, S.; Hemmatazad, H. (2023). OC-0270 Metastases-directed SRT and systemic therapy: EORTC-ESTRO OligoCare delphi consensus recommendations. Radiotherapy and oncology, S205-S206. Elsevier

Henzen, Dominik; Schmidhalter, Daniel; Guyer, Gian; Stenger-Weisser, Anna; Ermiş, Ekin; Poel, Robert; Deml, Moritz Caspar; Fix, Michael Karl; Manser, Peter; Aebersold, Daniel Matthias; Hemmatazad, Hossein (2022). Feasibility of postoperative spine stereotactic body radiation therapy in proximity of carbon and titanium hybrid implants using a robotic radiotherapy device. Radiation oncology, 17(1), p. 94. BioMed Central 10.1186/s13014-022-02058-7

Correia, Dora; Moullet, Barbara; Cullmann, Jennifer; Heiss, Rafael; Ermis, Ekin; Aebersold, Daniel M.; Hemmatazad, Hossein (2022). Response assessment after stereotactic body radiation therapy for spine and non-spine bone metastases: results from a single institutional study. Radiation oncology, 17(1), p. 37. BioMed Central 10.1186/s13014-022-02004-7

Guckenberger, M.; Alongi, F.; Ricardi, U.; Scorsetti, M.; Balermpas, P.; Livi, L.; Lievens, Y.; Braam, P.; Jereczek- Fossa, B.A.; Stellamans, K.; Ratosa, I.; Peulen, H.; Widder, J.; Ramella, S.; Verbeke, L.; Dirix, P.; Khanfir, K.; Zilli, T.; Hemmatazad, H.; Jeene, P.; ... (2022). OC-0599 Factors associated with SBRT doses in oligometastatic disease: an EORTC/ESTRO OligoCare analysis. Radiotherapy and oncology, 170, S523-S524. Elsevier 10.1016/S0167-8140(22)02621-4

Hemmatazad, Hossein; Mathier, Etienne; Aebersold, Daniel M.; Shelan, Mohamed (2021). [Single dose of 24 Gy or 3-fraction SBRT regimen in the treatment of oligometastatic cancer? : A phase III multi-center trial]. Strahlentherapie und Onkologie, 197(9), pp. 859-861. Springer 10.1007/s00066-021-01806-0

Stutz, Emanuel; Wartenberg, Martin; Hemmatazad, Hossein (2021). Case Report: Epidural tumor pseudoprogression after spine SBRT: A case report and a mini review of the literature. RAS Oncology & Therapy, 2(2) RAS Publishers

Hemmatazad, Hossein; Berger, Martin D. (2021). CCR5 is a potential therapeutic target for cancer. Expert opinion on therapeutic targets, 25(4), pp. 311-327. Taylor & Francis 10.1080/14728222.2021.1902505

Stenger-Weisser, Anna; Daneshvar Ghorbani, Keivan; Hemmatazad, Hossein (2021). Local control and radiological changes after stereotactic radiotherapy of sternal metastases using skin surface markers: A descriptive case series and mini-review of literature. Oncology & Cancer Case Reports, 07(2), 001-007. IOMC

Schmidhalter, Daniel; Henzen, Dominik; Herrmann, Evelyn; Volken, Werner; Terribilini, Dario; Frei, Daniel; Mackeprang, Paul-Henry; Ermis, Ekin; Hemmatazad, Hossein; Honegger, Jonas; Haas, Benjamin; Fix, Michael; Manser, Peter (28 November 2020). Frameless workflow for radiosurgery of arteriovenous malformations - A new software prototype (Unpublished). In: ESTRO Annual Meeting.

Rüfenacht, Elias; Jungo, Alain; Ermis, Ekin; Hemmatazad, Hossein; Blatti, Marcela Judith; Aebersold, Daniel; Manser, Peter; Fix, Michael; Reyes, Mauricio; Herrmann, Evelyn (December 2019). Fully automated organs at risk delineation for brain tumor radiation planning in patients with glioblastoma using deep learning. Strahlentherapie und Onkologie, 195(12), p. 1149. Berlin Heidelberg: Springer

Hemmatazad, Hossein; Schmidhalter, Daniel; Eliçin, Olgun; Aebersold, Daniel; Herrmann, Evelyn (2019). Skin surface markers for stereotactic body radiation therapy of sternal metastasis. Reports of practical oncology and radiotherapy, 24(4), pp. 322-324. Elsevier 10.1016/j.rpor.2019.05.005

Ermis, Ekin; Blatti, Marcela Judith; Leiser, Dominic; Cihoric, Nikola; Schmidhalter, Daniel; Henzen, Dominik; Malthaner, Marco; Hemmatazad, Hossein; Tsikkinis, Alexandros; Sermaxhaj, Burim; Aebersold, Daniel M.; Herrmann, Evelyn (2019). Dose analysis of InCise 2 multi leaf collimator and IRIS-based stereotactic radiotherapy plans for brain and liver tumors. Biomedical physics & engineering express, 5(3), 035007. IOP Publishing 10.1088/2057-1976/ab0beb

Rüfenacht, Elias; Jungo, Alain; Ermis, Ekin; Blatti-Moreno, Marcela; Hemmatazad, Hossein; Aebersold, Daniel M.; Fix, Michael; Manser, Peter; Reyes, Mauricio; Herrmann, Evelyn (2019). Organs at Risk Delineation for Brain Tumor Radiation Planning in Patients with Glioblastoma Using Deep Learning. International journal of radiation oncology, biology, physics, 105(1), E718-E719. Elsevier 10.1016/j.ijrobp.2019.06.892

Poel, R.; Belosi, F.; Klippel, Norbert; Albertini, F.; Walser, M.; Gisep, A.; Terribilini, Dario; Joosten, Andreas; Hemmatazad, Hossein; Zaugg, Kathrin; Aebersold, Daniel; Manser, Peter; Weber, Damien (2019). EP-1733 CFR-PEEK vs titanium spinal stabilization implants in photon and proton therapy: A phantom study. Radiotherapy and oncology, 133, S934-S935. Elsevier 10.1016/S0167-8140(19)32153-X

Schmidhalter, Daniel; Henzen, Dominik; Herrmann, Evelyn; Volken, Werner; Mackeprang, Paul-Henry; Ermis, Ekin; Hemmatazad, Hossein; Honegger, Jonas; Haas, Benjamin; Fix, Michael; Manser, Peter (2019). Evaluation of a new software prototype for frameless radiosurgery of arteriovenous malformations. Radiation oncology, 14(1), pp. 1-13. BioMed Central 10.1186/s13014-019-1422-x

Fix, Michael K.; Frei, Daniel; Volken, Werner; Terribilini, Dario; Müller, Silvan Andreas; Eliçin, Olgun; Hemmatazad, Hossein; Aebersold, Daniel M.; Manser, Peter (2018). Part 1: Optimization and evaluation of dynamic trajectory radiotherapy. Medical physics, 45(9), pp. 4201-4212. American Association of Physicists in Medicine AAPM 10.1002/mp.13086

Schmidhalter, Daniel; Henzen, Dominik; Malthaner, Marco; Herrmann, Evelyn; Angelmann, S.; Hemmatazad, Hossein; Stieb, Sonja; Fix, Michael; Manser, Peter (2018). EP-2185: Evaluation of the CK-11 version for the Cyberknife M6. Radiotherapy and oncology, 127, S1207. Elsevier 10.1016/S0167-8140(18)32494-0

Provide Feedback